{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:02:37Z","timestamp":1772629357437,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00405-019-05614-2","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T06:06:51Z","timestamp":1567490811000},"page":"3467-3475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?"],"prefix":"10.1007","volume":"276","author":[{"given":"Stefan A.","family":"Rudhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes D.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Gehrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike L.","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Birk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melika","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris A.","family":"Stuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-6503","authenticated-orcid":false,"given":"Stephan","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"5614_CR1","first-page":"120","volume":"810","author":"U Leiter","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C (2014) Epidemiology of skin cancer. Adv Exp Med Biol 810:120\u2013140","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"5614_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2012","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM (2012) Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population. JAMA Dermatol 151(10):1081\u20131086. \nhttps:\/\/doi.org\/10.1001\/jamadermatol.2015.1187","journal-title":"JAMA Dermatol"},{"issue":"3","key":"5614_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","volume":"146","author":"HW Rogers","year":"2006","unstructured":"Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB et al (2006) Incidence estimate of nonmelanoma skin cancer in the United States. Arch Dermatol 146(3):283\u2013287. \nhttps:\/\/doi.org\/10.1001\/archdermatol.2010.19","journal-title":"Arch Dermatol"},{"issue":"8","key":"5614_CR4","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","volume":"25","author":"P Nagarajan","year":"2018","unstructured":"Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM et al (2018) Keratinocyte carcinomas: current concepts and future research priorities. Clin Cancer Res 25(8):2379\u20132391. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1122","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"5614_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","volume":"7","author":"Z Apalla","year":"2017","unstructured":"Apalla Z, Nashan D, Weller RB, Castellsague X (2017) Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb) 7(Suppl 1):5\u201319. \nhttps:\/\/doi.org\/10.1007\/s13555-016-0165-y","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"7","key":"5614_CR6","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/sj.jid.5700776","volume":"127","author":"JN Bouwes Bavinck","year":"2007","unstructured":"Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R et al (2007) Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127(7):1647\u20131656. \nhttps:\/\/doi.org\/10.1038\/sj.jid.5700776","journal-title":"J Invest Dermatol"},{"key":"5614_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/v9090254","volume":"12","author":"S Smola","year":"2017","unstructured":"Smola S (2017) Immunopathogenesis of HPV-associated cancers and prospects for immunotherapy. Viruses 12:9. \nhttps:\/\/doi.org\/10.3390\/v9090254","journal-title":"Viruses"},{"key":"5614_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.virol.2015.02.004","volume":"479\u2013480","author":"PM Howley","year":"2015","unstructured":"Howley PM, Pfister HJ (2015) Beta genus papillomaviruses and skin cancer. Virology 479\u2013480:290\u2013296. \nhttps:\/\/doi.org\/10.1016\/j.virol.2015.02.004","journal-title":"Virology"},{"key":"5614_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.virusres.2016.11.013","volume":"231","author":"M Tommasino","year":"2017","unstructured":"Tommasino M (2017) The biology of beta human papillomaviruses. Virus Res 231:128\u2013138. \nhttps:\/\/doi.org\/10.1016\/j.virusres.2016.11.013","journal-title":"Virus Res"},{"issue":"1","key":"5614_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/sonu.2003.50000","volume":"19","author":"AC Geller","year":"2003","unstructured":"Geller AC, Annas GD (2003) Epidemiology of melanoma and nonmelanoma skin cancer. Semin Oncol Nurs 19(1):2\u201311","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"5614_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1200\/JCO.2005.02.155","volume":"23","author":"GL Clayman","year":"2005","unstructured":"Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK et al (2005) Mortality risk from squamous cell skin cancer. J Clin Oncol 23(4):759\u2013765. \nhttps:\/\/doi.org\/10.1200\/JCO.2005.02.155","journal-title":"J Clin Oncol"},{"issue":"6","key":"5614_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","volume":"26","author":"Dan E. Rowe","year":"1992","unstructured":"Rowe DE, Carroll RJ, Day CL (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26(6):976\u201390.=","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"5614_CR13","first-page":"2433","volume":"34","author":"S Hoch","year":"2014","unstructured":"Hoch S, Franke N, Katabi N, Werner JA, Teymoortash A (2014) The value of elective parotidectomy in advanced squamous cell carcinoma of the skin of the head. Anticancer Res 34(5):2433\u20132436","journal-title":"Anticancer Res"},{"issue":"7","key":"5614_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/archotol.129.7.750","volume":"129","author":"CE Palme","year":"2003","unstructured":"Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ (2003) Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129(7):750\u2013753. \nhttps:\/\/doi.org\/10.1001\/archotol.129.7.750","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"5614_CR15","first-page":"61","volume":"53","author":"JL Pujol","year":"1993","unstructured":"Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, Michel FB (1993) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53(1):61\u201366","journal-title":"Cancer Res"},{"issue":"3","key":"5614_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(81)90170-7","volume":"25","author":"YJ Wu","year":"1981","unstructured":"Wu YJ, Rheinwald JG (1981) A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell 25(3):627\u2013635","journal-title":"Cell"},{"issue":"3","key":"5614_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000065476","volume":"63","author":"C Kuropkat","year":"2002","unstructured":"Kuropkat C, Lippert BM, Werner JA (2002) Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck. Oncology 63(3):280\u2013285. \nhttps:\/\/doi.org\/10.1159\/000065476","journal-title":"Oncology"},{"issue":"10","key":"5614_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/000348940511401006","volume":"114","author":"P Ceruse","year":"2005","unstructured":"Ceruse P, Rabilloud M, Charrie A, Dubreuil C, Disant F (2005) Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 114(10):768\u2013776. \nhttps:\/\/doi.org\/10.1177\/000348940511401006","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"5614_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000030152","volume":"22","author":"A Banal","year":"2001","unstructured":"Banal A, Hacene K, Berthelot-Ruff E, Mahe E, Fontana X, Pichon MF (2001) Comparison of Cyfra 21-1 and SCC assays in head and neck tumours. Tumour Biol 22(1):27\u201335. \nhttps:\/\/doi.org\/10.1159\/000030152","journal-title":"Tumour Biol"},{"issue":"3","key":"5614_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1258\/002221503321192485","volume":"117","author":"YF Deng","year":"2003","unstructured":"Deng YF, Chen P, Lin YZ, Le JZ, Wu XL, Yu MQ et al (2003) Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma. J Laryngol Otol 117(3):190\u2013194. \nhttps:\/\/doi.org\/10.1258\/002221503321192485","journal-title":"J Laryngol Otol"},{"issue":"8","key":"5614_CR21","first-page":"3421","volume":"29","author":"H Al-Shagahin","year":"2009","unstructured":"Al-Shagahin H, Alkotyfan K, Muller H-H, Sesterhenn AM, Werner JA (2009) Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma. Anticancer Res 29(8):3421\u20133425","journal-title":"Anticancer Res"},{"issue":"6","key":"5614_CR22","first-page":"2291","volume":"30","author":"K Alkotyfan","year":"2010","unstructured":"Alkotyfan K, Wiegand S, Muller H-H, Windfuhr JP, Werner JA, Sesterhenn AM (2010) Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx. Anticancer Res 30(6):2291\u20132296","journal-title":"Anticancer Res"},{"key":"5614_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12957-015-0656-9","volume":"13","author":"Y-P Hsu","year":"2015","unstructured":"Hsu Y-P, Hsieh C-H, Chien H-T, Lai C-H, Tsao C-K, Liao C-T et al (2015) Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma. World J Surg Oncol 13:253. \nhttps:\/\/doi.org\/10.1186\/s12957-015-0656-9","journal-title":"World J Surg Oncol"},{"key":"5614_CR24","volume-title":"TNM classification of malignant tumours","author":"C Wittekind","year":"2017","unstructured":"Wittekind C, Bootz F, Meyer HJ (2017) TNM classification of malignant tumours, 8th edn. Wiley, Hoboken","edition":"8"},{"issue":"6","key":"5614_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3892\/mco.2016.834","volume":"4","author":"M Ueda","year":"2016","unstructured":"Ueda M, Yasuda M, Shibaoka Y, Kurokawa I, Kakuno A, Tsubura A (2016) Keratin 19-positive cutaneous squamous cell carcinoma with elevated serum cytokeratin 19 fragment 21-1 level: a case report. Mol Clin Oncol 4(6):986\u2013988. \nhttps:\/\/doi.org\/10.3892\/mco.2016.834","journal-title":"Mol Clin Oncol"},{"issue":"12","key":"5614_CR26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1054\/bjoc.2000.1502","volume":"83","author":"I Doweck","year":"2000","unstructured":"Doweck I, Barak M, Uri N, Greenberg E (2000) The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease. Br J Cancer 83(12):1696\u20131701. \nhttps:\/\/doi.org\/10.1054\/bjoc.2000.1502","journal-title":"Br J Cancer"},{"issue":"1","key":"5614_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1365-2273.1998.00101.x","volume":"23","author":"TC Yen","year":"1998","unstructured":"Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ (1998) A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol Allied Sci 23(1):82\u201386","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"8","key":"5614_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/000348940111000814","volume":"110","author":"JK Lee","year":"2001","unstructured":"Lee JK, Hsieh JF, Tsai SC, Ho YJ, Sun SS, Kao CH (2001) Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 110(8):775\u2013778. \nhttps:\/\/doi.org\/10.1177\/000348940111000814","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"5614_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(82)90400-7","volume":"31","author":"R Moll","year":"1982","unstructured":"Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31(1):11\u201324","journal-title":"Cell"},{"issue":"4B","key":"5614_CR30","first-page":"2859","volume":"17","author":"AM Niemann","year":"1997","unstructured":"Niemann AM, Goeroegh T, Gottschlich S, Lippert BM, Werner JA (1997) Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN). Anticancer Res 17(4B):2859\u20132860","journal-title":"Anticancer Res"},{"issue":"12","key":"5614_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1258\/002221503322684000","volume":"117","author":"C Kuropkat","year":"2003","unstructured":"Kuropkat C, Werner JA (2003) Analytical and clinical evaluation of CYFRA 21\u20131 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma. J Laryngol Otol 117(12):1007\u20131008. \nhttps:\/\/doi.org\/10.1258\/002221503322684000\n\n(author reply 1008-9)","journal-title":"J Laryngol Otol"},{"issue":"2","key":"5614_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000276919","volume":"59","author":"PD Goumas","year":"1997","unstructured":"Goumas PD, Mastronikolis NS, Mastorakou AN, Vassilakos PJ, Nikiforidis GC (1997) Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 59(2):106\u2013114. \nhttps:\/\/doi.org\/10.1159\/000276919","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"2A","key":"5614_CR33","first-page":"917","volume":"23","author":"A Hoffmann-Fazel","year":"2003","unstructured":"Hoffmann-Fazel A, Hoffmann M, Gottschlich S, Maass JD, Rudert H, Maune S (2003) Cyfra 21-1 in diagnosis of distant metastases of head and neck carcinoma. Anticancer Res 23(2A):917\u2013920","journal-title":"Anticancer Res"},{"issue":"3B","key":"5614_CR34","first-page":"2241","volume":"20","author":"JD Maass","year":"2000","unstructured":"Maass JD, Hoffmann-Fazel A, Goeroegh T, Hoffmann M, Meyer JE, Gottschlich S et al (2000) Cyfra 21-1: a serological help for detection of distant metastases in head and neck cancer. Anticancer Res 20(3B):2241\u20132243","journal-title":"Anticancer Res"},{"issue":"2","key":"5614_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0970-9290.207789","volume":"28","author":"P Singh","year":"2017","unstructured":"Singh P, Barpande SR, Bhavthankar JD, Mandale MS, Bhagwat AU (2017) Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation. Indian J Dent Res 28(2):162\u2013168. \nhttps:\/\/doi.org\/10.4103\/0970-9290.207789","journal-title":"Indian J Dent Res"},{"issue":"8","key":"5614_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.oraloncology.2007.10.008","volume":"44","author":"SS Sawant","year":"2008","unstructured":"Sawant SS, Zingde SM, Vaidya MM (2008) Cytokeratin fragments in the serum: their utility for the management of oral cancer. Oral Oncol 44(8):722\u2013732. \nhttps:\/\/doi.org\/10.1016\/j.oraloncology.2007.10.008","journal-title":"Oral Oncol"},{"issue":"2","key":"5614_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/archotol.1995.01890020039009","volume":"121","author":"I Doweck","year":"1995","unstructured":"Doweck I, Barak M, Greenberg E, Uri N, Kellner J, Lurie M et al (1995) Cyfra 21\u20131. A new potential tumor marker for squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg 121(2):177\u2013181","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"S02","key":"5614_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0038-1640045","volume":"97","author":"S Hoch","year":"2018","unstructured":"Hoch S, Rudhart S, Stuck B et al (2018) Clinical impact of CYFRA 21-1 as a tumor marker for regional and distant tumor control in advanced oropharyngeal cancer. Laryngorhinootologie 97(S02):91\u201391. \nhttps:\/\/doi.org\/10.1055\/s-0038-1640045","journal-title":"Laryngorhinootologie"},{"key":"5614_CR39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1432-0436.1982.tb01291.x","volume":"23","author":"R Moll","year":"1983","unstructured":"Moll R, Krepler R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256\u2013269","journal-title":"Differentiation"},{"key":"5614_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hed.2880150209","volume":"15","author":"LA van der Velden","year":"1993","unstructured":"van der Velden LA, Schaafsma E, Manni JJ, Ramaekers FCS, Kuypers W (1993) Cytokeratin expression in normal and (pre)malignant head and neck epithelia: an overview. Head Neck 15:133\u2013146","journal-title":"Head Neck"},{"issue":"4","key":"5614_CR41","first-page":"376","volume":"12","author":"A Teymoortash","year":"2002","unstructured":"Teymoortash A, D\u00fcnne AA, Werner JA (2002) Parotideal lymph node metastasis in squamous cell carcinoma of the skin. Eur J Dermatol 12(4):376\u2013380","journal-title":"Eur J Dermatol"},{"issue":"10","key":"5614_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1055\/s-2007-966813","volume":"86","author":"A Teymoortash","year":"2007","unstructured":"Teymoortash A (2007) Parotid gland as the main site of metastasis of the cutaneous squamous cell carcinoma of the head. Laryngo-Rhino-Otol 86(10):699\u2013704","journal-title":"Laryngo-Rhino-Otol"},{"issue":"5B","key":"5614_CR43","first-page":"3117","volume":"16","author":"B Wollenberg","year":"1996","unstructured":"Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A (1996) CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res 16(5B):3117\u20133124","journal-title":"Anticancer Res"},{"issue":"1","key":"5614_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1278-3218(01)00110-X","volume":"6","author":"O Pradier","year":"2002","unstructured":"Pradier O, Hille A, Schmiberger H, Hess CF (2002) Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1. Cancer Radiother 6(1):15\u201321","journal-title":"Cancer Radiother"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-019-05614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-019-05614-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-019-05614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:10:47Z","timestamp":1599001847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-019-05614-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5614"],"URL":"https:\/\/doi.org\/10.1007\/s00405-019-05614-2","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that there is no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}